Stay updated on Kevetrin in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Kevetrin in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Kevetrin in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe record now displays details for the completed Kevetrin Phase 1 study, including its design, outcomes, eligibility criteria, enrollment, and sponsor information, instead of a forbidden-access error.SummaryDifference53%

- Check13 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden message.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA sitewide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check41 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check55 days agoChange DetectedAccess to the study record now displays a 403 Forbidden error, indicating restricted access. The page header shows the 403 message and a Home link is visible in the navigation.SummaryDifference19%

- Check62 days agoChange DetectedThe page shows Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating a new update to the page's content or structure without changing the trial data.SummaryDifference0.1%

Stay in the know with updates to Kevetrin in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Kevetrin in Advanced Solid Tumors Clinical Trial page.